Monsanto Company Sees Tremendous Progress In R&D Pipeline

ST. LOUIS, Jan. 4 /PRNewswire-FirstCall/ -- Monsanto Company reported on a remarkable year in research-and-development (R&D) advancements, highlighting progress across both its biotechnology and breeding platforms. The company’s announcement came as part of its first-quarter 2007 fiscal year conference call.

Monsanto reported on seven specific projects in the research-and- development pipeline that either advanced from one phase to the next or were added to the pipeline. The update also highlighted the company’s three High Impact Technology (HIT) projects.

“In the last two years, there has been positive movement in 70 percent of the projects in the pipeline,” said Robert T. Fraley, Ph.D., chief technology officer and executive vice president for Monsanto. “Of that advancement, almost half are from additions to the pipeline, reflecting the strength of our discovery engine and our collaborative efforts.”

The presentation outlined several key measures of progress including the three HIT projects:

-- Roundup RReady2Yield soybeans, the company’s next-generation, herbicide-tolerant technology in soybeans, moved to Phase 4. The movement, which was based on results from its 2006 breeding trials, advanced the technology one step closer to commercial launch. -- Vistive III soybeans, designed to have a similar oil profile to olive oil, met the company’s target composition profile on three of its genetic events. -- First-generation Drought Tolerant corn continued to demonstrate yield benefits in its third year of field testing. Other highlighted projects: -- Second-generation Drought Tolerant corn continued to complement the first-generation trait, with strong performance in both water-stressed and broad-acre field testing. -- Higher-Yielding corn advanced to Phase 2, with three of the company’s genetic events demonstrating a five percent to ten percent yield increase. -- Nitrogen Utilization corn technology events continued to demonstrate efficient use of nitrogen within testing environments, providing overall yield stability even as the amount of applied nitrogen decreased. -- High-Oil soybeans, a soybean project from Monsanto’s Renessen joint venture with Cargill, advanced to Phase 3 after the technology continued to demonstrate a clear oil yield advantage compared with conventional checks. Breeding a Better Seed

Fraley’s presentation was focused on the combined benefits of biotechnology and breeding, emphasizing the fact that both platforms drive plant science innovation.

“As excited as we are about the biotech pipeline, we understand that our success rides on the combination of biotechnology and breeding,” Fraley said. “We’ve put a lot of emphasis on making sure that -- before we ever look to biotechnology -- we have the best, highest yielding seed possible so farmers can start each season strong.”

Backed by the company’s breeding prowess, Monsanto’s national seed brands continue to offer farmers higher-yielding seeds, Fraley noted. In 2006, the yield advantage in Monsanto’s national corn brands was reinforced through more than 49,000 corn breeding comparisons, which highlighted a record 11.7 bushels per acre advantage for Monsanto’s DEKALB brand in the widely planted 110-day corn.

In soybeans, Fraley also highlighted a strategy that combines strong, conventional soy breeding capabilities with breakthrough applications of molecular breeding to more efficiently identify characteristics that are important to growers.

For the latest update on Monsanto’s R&D pipeline, direct links to Fraley’s presentation slides are archived on the company’s Web site in the “Investor Information” section at: http://www.monsanto.com/monsanto/layout/investor/financial/presentations.asp . To learn more about Monsanto’s pipeline, please visit: http://www.monsanto.com/monsanto/layout/investor/financial/RD_pipeline.asp .

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information, please visit: http://www.monsanto.com .

Note to editors: DEKALB, Monsanto and the Vine Design, Roundup RReady2Yield and VISTIVE are trademarks of Monsanto Company and its wholly owned subsidiaries

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this presentation are “forward-looking statements,” such as statements concerning the company’s anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company’s exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company’s research and development activities; the outcomes of major lawsuits, including proceedings related to Solutia Inc.; developments related to foreign currencies and economies; successful completion and operation of recent and proposed acquisitions, including Delta and Pine Land Company; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company’s estimates related to distribution inventory levels; the company’s ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company’s facilities; and other risks and factors detailed in the company’s most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this presentation. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Monsanto Company

CONTACT: Sara Duncan of Monsanto Company, +1-314-694-2729

MORE ON THIS TOPIC